Media can register now for ESTRO 36 - Europe's largest congress on radiation oncology

March 01, 2017

Registration has now opened for journalists for ESTRO 36 - Europe's largest congress on radiation oncology, organised by the European Society for Radiotherapy and Oncology (ESTRO).

ESTRO 36 takes place at the Reed Messe Vienna GmbH, Congress Centre, Messeplatz 1, A-1021 Vienna, Austria, 5 - 9 May 2017. Registration is free for journalists on provision of bona fide press credentials.

The ESTRO 36 congress will feature new research results in clinical radiation oncology, radiobiology, physics, technology, patient care, radiation therapy and brachytherapy, presented by top doctors, scientists, radiation therapists and cancer nurses from all over the world, working together for the benefit of cancer patients.

The congress is expected to attract 5,000 delegates from more than 80 countries.

The congress will cover the entire spectrum of radiotherapy, both external beam and internal beam with brachytherapy, and highlight what is new across fields as diverse as:
-end-
The ESTRO web site has full details about ESTRO 36, including the scientific programme, venue, accommodation, media registration etc.

Twitter hashtag: #ESTRO36

European Society for Radiotherapy and Oncology (ESTRO)

Related Radiotherapy Articles from Brightsurf:

Genomic analysis predicts survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in low-grade gliomas in NRG Oncology clinical trial
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.

Outcomes in radiotherapy-treated patients with cancer during COVID-19
The delivery of radiotherapy in 209 patients with cancer during the COVID-19 outbreak in Wuhan, China, is evaluated in this case series.

Shorter radiotherapy treatment for bowel cancer patients during COVID-19
An international panel of cancer experts has recommended a one-week course of radiotherapy and delaying surgery as the best way to treat patients with bowel cancer during the COVID-19 pandemic.

The pros and cons of radiotherapy: Will it work for you?
Women undergoing radiotherapy for many cancers are more likely than men to be cured, but the side effects are more brutal, according to one of Australia's most experienced radiation oncology medical physicists.

How to keep boron inside cells during radiotherapy: a novel approach to cancer treatment
Boron neutron capture therapy (BNCT) is a technique in which p-boronophenylalanine (BPA) is transferred to cancer cells, and the boron in it undergoes nuclear fission reaction upon irradiation of thermal neutrons, releasing high energy particles that kill the cells.

Prolonged breath-holding could help radiotherapy treatment of cardiac arrhythmias
A technique that enables patients suffering from heart conditions to hold their breath safely for over five minutes could have potential as part of a new treatment for cardiac arrhythmias, say researchers at the University of Birmingham.

Zebrafish 'avatars' can help decide who should receive radiotherapy treatment
To date, there is no method for clearly determining whether radiotherapy will be an effective treatment for individual cancer patients.

One dose of radiotherapy as effective as five doses for cancer in the spine
A single dose of radiotherapy is as 'effective' as five doses for end-of-life cancer patients suffering with painful spinal canal compression, finds a large study conducted by UCL.

Personalized and powerful: UK to lead next-generation radiotherapy research
The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today.

Oxygen in hyperbaric chamber provides relief after radiotherapy
Hyperbaric oxygen therapy (HBOT) can relieve self-reported symptoms and side-effects of radiotherapy against cancer in the pelvic region, a study shows.

Read More: Radiotherapy News and Radiotherapy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.